Cliff Asness’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Cliff Asness’s Portfolio AXN Stock Details AXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-45,700	Closed	-$80K	–	2327
2015 Q2	$80K	Buy	+45,700	New	+$81.3K	﹤0.01%	2179

Other funds holding AXN

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return

Cliff Asness's AXN Position: Q3 2015 in Review

Cliff Asness sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q3 2015, closing a stake of 45,700 shares — an estimated $80K sold.

Cliff Asness first reported a position in AXN in Q2 2015 and held it in 1 quarter. The position peaked at $80K in Q2 2015. 10 funds tracked by Wall St. Rank hold AXN as of Q3 2015.

Cliff Asness reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q3 2015 after selling out during the quarter.
Cliff Asness sold 45,700 Aoxing Pharmaceutical Company Inc. shares in Q3 2015, an estimated $80K.
Cliff Asness first reported a position in Aoxing Pharmaceutical Company Inc. in Q2 2015 and held it in 1 quarter.
Cliff Asness's Aoxing Pharmaceutical Company Inc. position peaked at $80K in Q2 2015.
10 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q3 2015.

Based on AQR Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.